Tivacay (Dolutegravir), is the new integrase inhibitor approved ny the FDA a few weeks ago for the treatment of HIV
Watch the Club MedZ Minute
Subscribe To Thriver News
Get our weekly updates
Share on Facebook Tweet (Share on Twitter) Share on Linkedin Share on Google+ Pin it (Share on Pinterest)